Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study

Volume: 21, Issue: 2, Pages: 198 - 205
Published: Feb 1, 2015
Abstract
Background:Safety data on first-trimester natalizumab exposure are scarce, as natalizumab is usually withdrawn three months before pregnancy.Objective:The objective of this paper is to investigate the fetal safety of exposure to natalizumab (Tysabri®) during the first trimester of pregnancy using disease-matched (DM) and healthy control (HC) comparison groups.Methods:A total of 101 German women with RRMS exposed to natalizumab during the first...
Paper Details
Title
Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study
Published Date
Feb 1, 2015
Volume
21
Issue
2
Pages
198 - 205
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.